These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28839258)

  • 21. Myoglobin variants are expressed in human glioblastoma cells‑hypoxia effect?
    El-Tohamy R; Elkholi I; Elsherbiny ME; Magdy M; Hammam O; Allalunis-Turner J; Emara M
    Oncol Rep; 2020 Mar; 43(3):975-985. PubMed ID: 32020230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
    Dréan A; Rosenberg S; Lejeune FX; Goli L; Nadaradjane AA; Guehennec J; Schmitt C; Verreault M; Bielle F; Mokhtari K; Sanson M; Carpentier A; Delattre JY; Idbaih A
    J Neurooncol; 2018 Jul; 138(3):479-486. PubMed ID: 29520610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
    Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
    World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis.
    Wen YD; Zhu XS; Li DJ; Zhao Q; Cheng Q; Peng Y
    Sci Rep; 2021 Aug; 11(1):17170. PubMed ID: 34446747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis.
    Liu Z; Han L; Dong Y; Tan Y; Li Y; Zhao M; Xie H; Ju H; Wang H; Zhao Y; Zheng Q; Wang Q; Su J; Fang C; Fu S; Jiang T; Liu J; Li X; Kang C; Ren H
    Oncotarget; 2016 Jan; 7(4):4680-94. PubMed ID: 26717039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells.
    Xie B; Zhang L; Hu W; Fan M; Jiang N; Duan Y; Jing D; Xiao W; Fragoso RC; Lam KS; Sun LQ; Li JJ
    Redox Biol; 2019 Jun; 24():101189. PubMed ID: 30986607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor gamma as a theragnostic target for mesenchymal-type glioblastoma patients.
    Hua TNM; Oh J; Kim S; Antonio JM; Vo VTA; Om J; Choi JW; Kim JY; Jung CW; Park MJ; Jeong Y
    Exp Mol Med; 2020 Apr; 52(4):629-642. PubMed ID: 32280134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
    Han J; Puri RK
    J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia.
    Wang P; Lan C; Xiong S; Zhao X; Shan Y; Hu R; Wan W; Yu S; Liao B; Li G; Wang J; Zou D; Chen B; Feng H; Wu N
    Oncotarget; 2017 Apr; 8(17):28074-28092. PubMed ID: 28427209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells Regulation.
    Karsy M; Guan J; Jensen R; Huang LE; Colman H
    World Neurosurg; 2016 Apr; 88():222-236. PubMed ID: 26724617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
    Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
    BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells.
    Mughal AA; Grieg Z; Skjellegrind H; Fayzullin A; Lamkhannat M; Joel M; Ahmed MS; Murrell W; Vik-Mo EO; Langmoen IA; Stangeland B
    Mol Cancer; 2015 Aug; 14():160. PubMed ID: 26292663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme.
    Wang K; Lu Y; Liu Z; Diao M; Yang L
    Biomed Res Int; 2022; 2022():7858477. PubMed ID: 35155681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Chromatin-Oxygen Sensor Gene
    Drongitis D; Verrillo L; De Marinis P; Orabona P; Caiola A; Turitto G; Alfieri A; Bruscella S; Gentile M; Moriello V; Sannino E; Di Muccio I; Costa V; Miano MG; de Bellis A
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142158
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Gonçalves CS; Vieira de Castro J; Pojo M; Martins EP; Queirós S; Chautard E; Taipa R; Pires MM; Pinto AA; Pardal F; Custódia C; Faria CC; Clara C; Reis RM; Sousa N; Costa BM
    Theranostics; 2018; 8(17):4805-4823. PubMed ID: 30279739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.
    Agrawal R; Garg A; Benny Malgulwar P; Sharma V; Sarkar C; Kulshreshtha R
    Int J Cancer; 2018 May; 142(9):1817-1828. PubMed ID: 29226333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA-FAM66C Was Identified as a Key Regulator for Modulating Tumor Microenvironment and Hypoxia-Related Pathways in Glioblastoma.
    Liu D; Wan Y; Qu N; Fu Q; Liang C; Zeng L; Yang Y
    Front Public Health; 2022; 10():898270. PubMed ID: 35874989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway.
    Jin P; Shin SH; Chun YS; Shin HW; Shin YJ; Lee Y; Kim D; Nam DH; Park JW
    Oncogene; 2018 Jun; 37(23):3070-3087. PubMed ID: 29535421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
    Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
    Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma.
    Cooper LA; Gutman DA; Chisolm C; Appin C; Kong J; Rong Y; Kurc T; Van Meir EG; Saltz JH; Moreno CS; Brat DJ
    Am J Pathol; 2012 May; 180(5):2108-19. PubMed ID: 22440258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.